Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial-Reference-Cited by-同舟云学术

Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial

Published:2021-09 Issue:3 Volume:225 Page:308.e1-308.e14
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Peguero Anna^ORCID,Herraiz Ignacio,Perales Alfredo,Melchor Juan Carlos,Melchor Iñigo,Marcos Beatriz,Villalain Cecilia,Martinez-Portilla Raigam,Mazarico Edurne,Meler Eva,Hernandez Sandra,Matas Isabel,del Rio Maria,Galindo Alberto,Figueras Francesc

Funder

Instituto de Salud Carlos III

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference26 articles.

1. The global impact of pre-eclampsia and eclampsia;Duley;Semin Perinatol,2009

2. Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis;Bernardes;Ultrasound Obstet Gynecol,2019

3. Planned early delivery or expectant management for late preterm pre-eclampsia (Phoenix): a randomised controlled trial;Chappell;Lancet,2019

4. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia;Zeisler;N Engl J Med,2016

5. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study;Chappell;Circulation,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of mechanistic advances in preeclampsia to the clinic: Long and winding road;The FASEB Journal;2024-02

2. La pré-éclampsie : recommandations pour la pratique clinique du Collège national des gynécologues obstétriciens français;Gynécologie Obstétrique Fertilité & Sénologie ;2024-01

3. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis;American Journal of Obstetrics and Gynecology;2023-09

4. Clinical utility of sFlt ‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction;Ultrasound in Obstetrics & Gynecology;2023-02

5. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology;American Journal of Obstetrics and Gynecology;2022-10